This Week in Nephrology — Oct 21, 2026

Editor's Pick: Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury (New England Journal of Medicine, 2026)

This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.

Welcome to This Week in Nephrology. This week we're covering 10 notable papers spanning acute kidney injury in the critically ill, kidney transplantation, and cardiometabolic and glomerular strategies in chronic kidney disease. Let's dive in.

This week's papers: 1. Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury. — New England Journal of Medicine 2026 2. Intraoperative Dobutamine Plus Norepinephrine to Prevent Postoperative Acute Kidney Injury in Septic Shock: A Randomized Clinical Trial. — JAMA 2026 3. Randomized Clinical Trial of Ringer's Lactate Versus Chloride-Reduced Saline-Dextrose in Postoperative Kidney Transplantation. — Kidney International Reports 2026 4. Claims-Based Phenotyping of Acute Kidney Transplant Rejection in a National Medicare Cohort. — Kidney International Reports 2026 5. Microvascular inflammation in kidney transplants: finally an effective treatment? — Kidney International 2026 6. Safety outcomes of semaglutide by chronic kidney disease severity in the FLOW trial. — Kidney International 2026 7. Glucagon-Like Peptide-1 Receptor Agonists and Multi-hormone Receptor Modulators for Kidney Protection in Nondiabetic Kidney Disease. — Journal of the American Society of Nephrology 2026 8. Aldosterone and Residual Cardiorenal Risk: Pathophysiology and Emerging Therapeutic Strategies. — Nephrology Dialysis Transplantation 2026 9. A study using the REIN registry suggests a statin therapy benefits for secondary prevention in patients receiving dialysis. — Kidney International 2026 10. Microangiopathic lesions associated with poor immunosuppressive therapy response in IgA nephropathy. — Nephrology Dialysis Transplantation 2026

Listen at https://audioscholar.cc/episode/sh4edd2nyb